Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.